Lipid A treatment enhances iNOS expression by activating NF-κB signaling cascades in the choroid plexus epithelium that is a part of the blood–CSF barrier against microbial pathogens and plays a crucial role in brain inflammatory processes in bacterial meningitis [149]. The gene discussed is NFKB1; the disease is bacterial meningitis.